Veltassa and Mircera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veltassa (patiromer sorbitex calcium) and Mircera (methoxy polyethylene glycol-epoetin beta). Common drug interactions include chest pain among females and haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Veltassa and Mircera. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Veltassa?

Veltassa has active ingredients of patiromer sorbitex calcium. eHealthMe is studying from 15,649 Veltassa users. Check the latest studies of Veltassa.

What is Mircera?

Mircera has active ingredients of methoxy polyethylene glycol-epoetin beta. eHealthMe is studying from 10,321 Mircera users. Check the latest studies of Mircera.

On Jul, 13, 2026

13 people who take Veltassa and Mircera together, and have interactions are studied.

What are the common drug interactions of Veltassa and Mircera, by gender? *:

female:

Chest pain
Drug hypersensitivity
Dyskinesia (abnormality or impairment of voluntary movement)
Erythema (redness of the skin)
Foaming at mouth (excess saliva secretion)
Hypotension (abnormally low blood pressure)
Loss of consciousness
Unresponsive to stimuli
Constipation
Nausea (feeling of having an urge to vomit)

male:

Haemorrhage (bleeding)
Malaise (a feeling of general discomfort or uneasiness)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
Hospitalisation
Death
Renal impairment (severely reduced kidney function)
Atrioventricular block (heart block)
Cardiac arrest
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Veltassa and Mircera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Death

40-49:

n/a

50-59:

Renal impairment (severely reduced kidney function)

60+:

Chest pain
Drug hypersensitivity
Constipation
Nausea (feeling of having an urge to vomit)
Vomiting
Atrioventricular block (heart block)
Cardiac arrest
Dyspnoea (difficult or laboured respiration)
Malaise (a feeling of general discomfort or uneasiness)
Pulseless electrical activity

What are the existing conditions these people have? *

Hyperkalemia (damage to or disease of the kidney): 7 people, 53.85%
Anaemia (lack of blood): 2 people, 15.38%
Phosphorus Metabolism Disorder: 1 person, 7.69%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 7.69%
Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 7.69%
Hypotension (abnormally low blood pressure): 1 person, 7.69%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Gout (uric acid crystals building up in the body): 1 person, 7.69%
Acidosis (build-up of carbon dioxide in the blood): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Veltassa and Mircera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously